Lifestyle and Environment · Environmental Exposures

Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis

Gou X, Wang Y, Tang Y, Qu Y, Tang J, Shi J, Xiao D, Mu D

Published March 2019 The Australian and New Zealand journal of psychiatry, 53(3), 195-206
DOI 10.1177/0004867418823276 PMID 30654621

Abstract

Background

Acetaminophen is a widely used medication for fever and pain management during pregnancy. However, recent studies have found a possible connection between maternal prenatal acetaminophen use and attention deficit/hyperactivity disorder in children.

Objective

We aimed to explore the association between maternal acetaminophen use during pregnancy and the risk of attention deficit/hyperactivity disorder in offspring.

Data Sources

PubMed, Embase, Web of Science and Cochrane Library were searched from their initial publications through November 2018 for studies.

Study Selection

We included all studies that examined the association between maternal acetaminophen use during pregnancy and the risk of attention deficit/hyperactivity disorder in offspring if the authors reported odds ratios, risk ratios, hazard ratios, regression coefficient, standard error and 95% confidence intervals.

Data Extraction and Synthesis

Two reviewers independently extracted data on the definition of exposure and outcome, exposed, non-exposed and total number of participants in the sample population, adjusted potential confounders and outcome parameters. Study quality was also assessed.

Results

Eight cohort studies with a total of 244,940 participants were included. Maternal exposure to acetaminophen during pregnancy increased the risk of attention deficit/hyperactivity disorder in offspring with a pooled adjusted risk ratio of 1.25 (95% confidence interval = [1.17, 1.34]). Children exposed prenatally to acetaminophen in the third trimester seemed to have the greatest risk of developing attention deficit/hyperactivity disorder (risk ratio: 1.26; 95% confidence interval = [1.08, 1.47]). In addition, a longer duration of maternal acetaminophen use during pregnancy was correlated with a higher risk ratio. Children whose mothers used acetaminophen for 28 or more days during gestation had a higher risk of developing attention deficit/hyperactivity disorder (risk ratio: 1.63; 95% confidence interval = [1.23, 2.16]).

Conclusion

There is an association between maternal acetaminophen use during pregnancy and the risk of attention deficit/hyperactivity disorder in offspring. The timing and duration of acetaminophen use during pregnancy may have a major effect on the risk of attention deficit/hyperactivity disorder.

Topics

By this author

Related research

Lifestyle and Environment › Environmental Exposures › Endocrine Disrupting Chemicals · Therapeutics › Prescribing Safety › Medication Safety in Pregnancy
Xiaoyun Gou, Yan Wang, Ying Tang, Yi Qu, Jun Tang, Jing Shi, Dongqiong Xiao, Dezhi Mu
X Gou, Y Wang, Y Tang, Y Qu, J Tang, J Shi, D Xiao, D Mu
PMID 30654621 30654621 DOI 10.1177/0004867418823276 10.1177/0004867418823276 Gou et al. 2019, Gou 2019